Loading clinical trials...
Loading clinical trials...
Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Samsung Medical Center
NCT07016620 · Benign Prostatic Hyperplasia (BPH)
NCT06817733 · Benign Prostatic Hyperplasia (BPH)
NCT04757116 · Benign Prostatic Hyperplasia (BPH)
NCT06983444 · Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection, Benign Prostatic Hyperplasia With Outflow Obstruction, and more
NCT02026908 · Benign Prostatic Hyperplasia (BPH)
Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions